The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects.
about
Identification of rifampin-regulated functional modules and related microRNAs in human hepatocytes based on the protein interaction networkDovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction.Preclinical assessment of the interactions between the antiretroviral drugs, ritonavir and efavirenz, and the tyrosine kinase inhibitor erlotinib.Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLC.Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib.Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.Precision, accuracy, and resolution-Dose selection of oral anticancer agents.Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
P2860
Q28597149-91721D87-20BC-45AD-9541-691E2C85867DQ33165980-E09C57A9-FF33-4D84-9C84-363BAEE37C58Q36080621-5BCCC7DF-1E48-4430-952E-6EC8F4394B11Q38719273-621B3556-464F-41E1-AF25-88D9920290F9Q38818845-3281CE22-CD7E-4895-BC49-586DD7EADD4BQ39031326-8ED7E588-1211-4379-A3EB-7BB3F9C24E6DQ41342988-1683E516-72CA-49BC-826A-6A68278BCED2Q54178349-48560EE9-6D24-434B-8093-0AC586F296F8Q54467809-7D677E22-CEE8-4574-AC50-C9B358BA337CQ58774388-B7E15D2C-D853-4F7F-AE92-1FAD5906CB12
P2860
The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@en
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@nl
type
label
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@en
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@nl
prefLabel
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@en
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@nl
P2093
P2860
P1476
The effect of rifampicin, a pr ...... okinetics in healthy subjects.
@en
P2093
Ashok K Rakhit
Bert L Lum
Daniel W Drolet
Julie L Wolf
Karsten Witt
Marta Hamilton
Scott H Fettner
P2860
P2888
P304
P356
10.1007/S00280-014-2390-3
P577
2014-01-29T00:00:00Z